{"id":8203,"date":"2023-08-23T10:14:22","date_gmt":"2023-08-23T14:14:22","guid":{"rendered":"https:\/\/vaccines.phila.gov\/?post_type=lsvr_notice&#038;p=8203"},"modified":"2025-01-15T10:24:09","modified_gmt":"2025-01-15T15:24:09","slug":"rsv-townhall-to-discuss-nirsevimab","status":"publish","type":"post","link":"https:\/\/vaccines.phila.gov\/index.php\/rsv-townhall-to-discuss-nirsevimab\/","title":{"rendered":"RSV Townhall to Discuss Nirsevimab"},"content":{"rendered":"\n<p class=\"has-large-font-size\"><strong>RSV Townhall to Discuss Nirsevimab<\/strong><\/p>\n\n\n\n<p>Come learn about the newly approved monoclonal antibody, nirsevimab (Beyfortus), to prevent RSV in neonates and young infants at a townhall hosted by the Philadelphia Immunization Program.&nbsp;<\/p>\n\n\n\n<p><strong>The townhall will take place over Zoom on Tuesday August 29 at 12pm.<\/strong><\/p>\n\n\n\n<p>Nirsevimab will be available to order through the VFC Program this fall. Prepare your practice for ordering and administration of the product at next week&#8217;s townhall.&nbsp;<\/p>\n\n\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-16018d1d wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button has-custom-font-size\" style=\"font-size:16px;letter-spacing:1px\"><a class=\"wp-block-button__link has-white-color has-text-color has-background has-text-align-center wp-element-button\" href=\"https:\/\/pdph-phila-gov.zoom.us\/meeting\/register\/tZMuce6rpz0rHNI6PZKnO4NbeR91HncuyoIh#\/registration\" style=\"background-color:#ff7474\"><strong>Register today!<\/strong><\/a><\/div>\n<\/div>\n\n\n\n<p> <\/p>\n\n\n\n<p><a href=\"https:\/\/vaccines.phila.gov\/index.php\/advisory-and-updates\/\">View past email advisories<\/a> and <a href=\"https:\/\/vaccines.phila.gov\/index.php\/events\/\">keep up with important events<\/a> on our website. We look forward to seeing you soon!<\/p>\n","protected":false},"excerpt":{"rendered":"<p>RSV Townhall to Discuss Nirsevimab Come learn about the newly approved monoclonal antibody, nirsevimab (Beyfortus), to prevent RSV in neonates and young infants at a townhall hosted by the Philadelphia Immunization Program.&nbsp; The townhall will take place over Zoom on Tuesday August 29 at 12pm&#8230;.<\/p>\n","protected":false},"author":22,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[145,139],"tags":[],"class_list":["post-8203","post","type-post","status-publish","format-standard","hentry","category-events","category-vfc"],"_links":{"self":[{"href":"https:\/\/vaccines.phila.gov\/index.php\/wp-json\/wp\/v2\/posts\/8203","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vaccines.phila.gov\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vaccines.phila.gov\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vaccines.phila.gov\/index.php\/wp-json\/wp\/v2\/users\/22"}],"replies":[{"embeddable":true,"href":"https:\/\/vaccines.phila.gov\/index.php\/wp-json\/wp\/v2\/comments?post=8203"}],"version-history":[{"count":0,"href":"https:\/\/vaccines.phila.gov\/index.php\/wp-json\/wp\/v2\/posts\/8203\/revisions"}],"wp:attachment":[{"href":"https:\/\/vaccines.phila.gov\/index.php\/wp-json\/wp\/v2\/media?parent=8203"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vaccines.phila.gov\/index.php\/wp-json\/wp\/v2\/categories?post=8203"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vaccines.phila.gov\/index.php\/wp-json\/wp\/v2\/tags?post=8203"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}